$REAL
TheRealReal, Inc. Stock $real

$real Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000157322122000041 Filed on February 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$145.1M	$467.7M	$86.27M
YoY Change	68.22%	55.92%	-6.28%
Cost Of Revenue	$64.50M	$194.2M	$33.45M
YoY Change	92.82%	72.82%	7.28%
Gross Profit	$80.63M	$273.5M	$52.82M
YoY Change	52.64%	45.8%	-13.21%
Gross Profit Margin	55.56%	58.47%	61.23%
Selling, General & Admin	$125.2M	$176.4M	$101.7M
YoY Change	23.08%	25.43%	19.11%
% of Gross Profit	155.29%	64.51%	192.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.691M	$23.53M	$5.180M
YoY Change	9.86%	24.87%	33.85%
% of Gross Profit	7.06%	8.6%	9.81%
Operating Expenses	$125.2M	$488.4M	$101.7M
YoY Change	23.08%	35.52%	19.11%
Operating Profit	-$44.58M	-$214.9M	-$48.91M
YoY Change	-8.85%	24.36%	99.23%
Interest Expense	-$6.041M	$21.53M	-$2.290M
YoY Change	163.8%	309.02%	-240.49%
% of Operating Profit
Other Income/Expense, Net	$1.000K	$23.00K	-$80.00K
YoY Change	-101.25%	-113.61%
Pretax Income	-$52.22M	-$236.1M	-$51.28M
YoY Change	1.84%	34.33%	123.83%
Income Tax	-$27.00K	$56.00K	$60.00K
% Of Pretax Income
Net Earnings	-$52.20M	-$236.1M	-$51.34M
YoY Change	1.67%	34.28%	122.64%
Net Earnings / Revenue	-35.97%	-50.48%	-59.51%
Basic Earnings Per Share		-$2.58
Diluted Earnings Per Share	-$563.3K	-$2.58	-$578.0K
COMMON SHARES
Basic Shares Outstanding	92.39M shares	91.41M shares
Diluted Shares Outstanding		91.41M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$418.2M	$418.2M	$354.9M
YoY Change	17.84%	17.83%	-2.31%
Cash & Equivalents	$418.2M	$139.4M	$350.8M
Short-Term Investments	$0.00	$0.00	$4.017M
Other Short-Term Assets	$20.86M	$20.86M	$17.10M
YoY Change	21.98%	21.98%	23.91%
Inventory	$71.02M	$71.02M	$42.32M
Prepaid Expenses
Receivables	$7.767M	$7.767M	$7.213M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$517.8M	$517.8M	$421.5M
YoY Change	22.86%	22.85%	3.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$89.29M	$234.6M	$63.45M
YoY Change	40.71%	29.18%	13.65%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.535M	$2.535M	$2.050M
YoY Change	23.66%	20.71%	-22.93%
Total Long-Term Assets	$237.1M	$237.1M	$183.6M
YoY Change	29.13%	29.16%	213.96%
TOTAL ASSETS
Total Short-Term Assets	$517.8M	$517.8M	$421.5M
Total Long-Term Assets	$237.1M	$237.1M	$183.6M
Total Assets	$754.9M	$754.9M	$605.1M
YoY Change	24.76%	24.76%	30.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.503M	$4.503M	$14.35M
YoY Change	-68.61%	-68.51%	28.56%
Accrued Expenses	$71.04M	$180.1M	$57.05M
YoY Change	24.52%	36.13%	8.01%
Deferred Revenue	$3.387M		$1.617M
YoY Change	109.46%		-66.08%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$188.0M	$188.0M	$148.3M
YoY Change	26.79%	26.76%	25.07%
LONG-TERM LIABILITIES
Long-Term Debt	$348.4M	$348.4M	$149.2M
YoY Change	133.5%	133.5%
Other Long-Term Liabilities	$2.291M	$145.5M	$1.284M
YoY Change	78.43%	24.96%	-86.42%
Total Long-Term Liabilities	$2.291M	$493.8M	$1.284M
YoY Change	78.43%	85.93%	-86.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$188.0M	$188.0M	$148.3M
Total Long-Term Liabilities	$2.291M	$493.8M	$1.284M
Total Liabilities	$681.8M	$681.8M	$413.8M
YoY Change	64.76%	64.77%	223.29%
SHAREHOLDERS EQUITY
Retained Earnings	-$768.1M		-$532.0M
YoY Change	44.38%		49.36%
Common Stock	$1.000K		$1.000K
YoY Change	0.0%		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$73.13M	$73.13M	$191.3M
YoY Change
Total Liabilities & Shareholders Equity	$754.9M	$754.9M	$605.1M
YoY Change	24.76%	24.76%	30.06%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$52.20M	-$236.1M	-$51.34M
YoY Change	1.67%	34.28%	122.64%
Depreciation, Depletion And Amortization	$5.691M	$23.53M	$5.180M
YoY Change	9.86%	24.87%	33.85%
Cash From Operating Activities	-$18.76M	-$142.2M	-$38.40M
YoY Change	-51.14%	5.75%	-1157.85%
INVESTING ACTIVITIES
Capital Expenditures	-$9.679M	$37.47M	-$4.600M
YoY Change	110.41%	105.28%	-59.11%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$4.000M	$48.07M
YoY Change	-100.0%	-98.05%	-123.66%
Cash From Investing Activities	-$9.679M	-$43.44M	$43.46M
YoY Change	-122.27%	-124.4%	-120.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.341M
YoY Change		140.84%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.805M	$252.9M	2.700M
YoY Change	-33.15%	65.5%	1073.91%
NET CHANGE
Cash From Operating Activities	-18.76M	-$142.2M	-38.40M
Cash From Investing Activities	-9.679M	-$43.44M	43.46M
Cash From Financing Activities	1.805M	$252.9M	2.700M
Net Change In Cash	-26.64M	$67.33M	7.760M
YoY Change	-443.27%	-65.72%	-103.69%
FREE CASH FLOW
Cash From Operating Activities	-$18.76M	-$142.2M	-$38.40M
Capital Expenditures	-$9.679M	$37.47M	-$4.600M
Free Cash Flow	-$9.085M	-$179.6M	-$33.80M
YoY Change	-73.12%	17.65%	-327.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Registrant Name EntityRegistrantName	TheRealReal, Inc.
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001573221
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-38953
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-1234222
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	55 Francisco Street
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 600
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94133
CY2021	dei	City Area Code CityAreaCode	855
CY2021	dei	Local Phone Number LocalPhoneNumber	435-5893
CY2021	dei	Security12b Title Security12bTitle	Common stock, $0.00001 par value
CY2021	dei	Trading Symbol TradingSymbol	REAL
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	1524824900	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	93055388	shares
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021	dei	Auditor Name AuditorName	KPMG
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	418171000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	350846000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4017000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7767000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7213000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	71015000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	42321000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20859000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17072000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	517812000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	421469000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	187986000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	148260000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89286000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	63454000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	145311000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118136000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2535000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2050000	USD
CY2021Q4	us-gaap	Assets Assets	754944000	USD
CY2020Q4	us-gaap	Assets Assets	605109000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4503000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14346000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	71042000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57053000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	18253000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14999000	USD
CY2021Q4	real	Other Accrued And Current Liabilities OtherAccruedAndCurrentLiabilities	94188000	USD
CY2020Q4	real	Other Accrued And Current Liabilities OtherAccruedAndCurrentLiabilities	61862000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	143159000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	115084000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	348380000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	149188000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2291000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1284000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	681816000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	413816000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	92960066	shares
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299949000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	316354000	USD
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	92960066	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89301664	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89301664	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	841255000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	723302000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	11000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-768128000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-532021000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	191293000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	754944000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	605109000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	467692000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	194215000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	112382000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	114831000	USD
CY2021	us-gaap	Gross Profit GrossProfit	273477000	USD
CY2020	us-gaap	Gross Profit GrossProfit	187567000	USD
CY2019	us-gaap	Gross Profit GrossProfit	201523000	USD
CY2021	us-gaap	Marketing Expense MarketingExpense	62749000	USD
CY2020	us-gaap	Marketing Expense MarketingExpense	54813000	USD
CY2019	us-gaap	Marketing Expense MarketingExpense	47734000	USD
CY2021	real	Operations And Technology Expense OperationsAndTechnologyExpense	235829000	USD
CY2020	real	Operations And Technology Expense OperationsAndTechnologyExpense	163808000	USD
CY2019	real	Operations And Technology Expense OperationsAndTechnologyExpense	143231000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	176418000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	140652000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	110663000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	13389000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	360383000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	301628000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	23000	USD
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1110000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	488385000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-214908000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-172816000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-100105000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	365000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	2518000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	4593000	USD
CY2021	us-gaap	Interest Expense InterestExpense	21531000	USD
CY2020	us-gaap	Interest Expense InterestExpense	5264000	USD
CY2019	us-gaap	Interest Expense InterestExpense	616000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-169000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-101784000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2102000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-236051000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-175731000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98230000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	199000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-236107000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175832000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-98429000	USD
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2020	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2019	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	3355000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236107000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-175832000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.01
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.14
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.14
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91409624	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91409624	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87587409	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87587409	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47478544	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47478544	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-236107000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175832000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-98429000	USD
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-11000	USD
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	4000	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	32000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-236118000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-175828000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-98397000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-257690000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-3355000	USD
CY2019	real	Stock Issued During Period Value Conversion Of Redeemable Convertible Preferred Stock To Common Stock In Connection With Initial Public Offering StockIssuedDuringPeriodValueConversionOfRedeemableConvertiblePreferredStockToCommonStockInConnectionWithInitialPublicOffering	198228000	USD
CY2019	real	Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock In Connection With Initial Public Offering StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockInConnectionWithInitialPublicOffering	169102000	USD
CY2019	real	Adjustment To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrants To Common Stock Warrants In Connection With Initial Public Offering AdjustmentToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantsToCommonStockWarrantsInConnectionWithInitialPublicOffering	2710000	USD
CY2019	real	Issuance Of Stock Net Of Issuance Costs IssuanceOfStockNetOfIssuanceCosts	5333000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	315518000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2696000	USD
CY2019	real	Stock Issued During Period Value Warrant Exercised StockIssuedDuringPeriodValueWarrantExercised	33000	USD
CY2019	real	Stock Issued During Period Value Common Stock Upon Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes StockIssuedDuringPeriodValueCommonStockUponVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes	-130000	USD
CY2019	real	Stock Issued During Period Value Cashless Warrant Exercised StockIssuedDuringPeriodValueCashlessWarrantExercised	0	USD
CY2019	real	Adjustments To Additional Paid In Capital Share Based Compensation Related To Stock Sales By Current Employees AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRelatedToStockSalesByCurrentEmployees	819000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7711000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	32000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-98429000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	337245000	USD
CY2020	real	Purchase Of Capped Calls PurchaseOfCappedCalls	22546000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	19020000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8859000	USD
CY2020	real	Stock Issued During Period Value Conversion Of Redeemable Convertible Preferred Stock To Common Stock In Connection With Initial Public Offering StockIssuedDuringPeriodValueConversionOfRedeemableConvertiblePreferredStockToCommonStockInConnectionWithInitialPublicOffering	-751000	USD
CY2020	real	Stock Issued During Period Value Conversion Of Convertible Preferred Stock To Common Stock In Connection With Initial Public Offering StockIssuedDuringPeriodValueConversionOfConvertiblePreferredStockToCommonStockInConnectionWithInitialPublicOffering	972000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24322000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-175832000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	191293000	USD
CY2021	real	Purchase Of Capped Calls PurchaseOfCappedCalls	33666000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	93031000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6009000	USD
CY2021	real	Stock Issued During Period Value Common Stock Upon Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes StockIssuedDuringPeriodValueCommonStockUponVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes	-8000	USD
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2341000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50246000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-236107000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	73128000	USD
CY2021	us-gaap	Profit Loss ProfitLoss	-236107000	USD
CY2020	us-gaap	Profit Loss ProfitLoss	-175832000	USD
CY2019	us-gaap	Profit Loss ProfitLoss	-98429000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	23531000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18845000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13408000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	48802000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	24322000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	7711000	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-546000	USD
CY2019	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	0	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1034000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	903000	USD
CY2019	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	0	USD
CY2021	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	19439000	USD
CY2020	real	Reduction Of Operating Lease Right Of Use Assets ReductionOfOperatingLeaseRightOfUseAssets	16062000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1371000	USD
CY2021	real	Compensation Expense Related To Stock Sales By Current And Former Employees CompensationExpenseRelatedToStockSalesByCurrentAndFormerEmployees	0	USD
CY2020	real	Compensation Expense Related To Stock Sales By Current And Former Employees CompensationExpenseRelatedToStockSalesByCurrentAndFormerEmployees	0	USD
CY2019	real	Compensation Expense Related To Stock Sales By Current And Former Employees CompensationExpenseRelatedToStockSalesByCurrentAndFormerEmployees	819000	USD
CY2021	real	Change In Fair Value Of Convertible Preferred Stock Warrant Liability ChangeInFairValueOfConvertiblePreferredStockWarrantLiability	0	USD
CY2020	real	Change In Fair Value Of Convertible Preferred Stock Warrant Liability ChangeInFairValueOfConvertiblePreferredStockWarrantLiability	0	USD
CY2019	real	Change In Fair Value Of Convertible Preferred Stock Warrant Liability ChangeInFairValueOfConvertiblePreferredStockWarrantLiability	2100000	USD
CY2021	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	950000	USD
CY2020	real	Accrued Interest On Convertible Notes AccruedInterestOnConvertibleNotes	216000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4108000	USD
CY2021	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	13989000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-280000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
CY2020	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	2399000	USD
CY2019	real	Accretion Of Debt Discounts And Issuance Costs AccretionOfDebtDiscountsAndIssuanceCosts	11000	USD
CY2021	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	-10000	USD
CY2020	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	86000	USD
CY2019	real	Amortization Of Premiums Discounts On Short Term Investments AmortizationOfPremiumsDiscountsOnShortTermInvestments	226000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1588000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	337000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1579000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28694000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	20405000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11561000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	4009000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3443000	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	638000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-548000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1026000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15285000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-12752000	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9989000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2800000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6010000	USD
CY2021	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	13989000	USD
CY2020	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	4233000	USD
CY2019	real	Increase Decrease In Accrued Consignor Payable IncreaseDecreaseInAccruedConsignorPayable	17561000	USD
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	30922000	USD
CY2020	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	7994000	USD
CY2019	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	10686000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	947000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-166000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2762000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-142151000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-134419000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54490000	USD
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	73280000	USD
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	220609000	USD
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	4000000	USD
CY2020	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	278215000	USD
CY2019	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	39281000	USD
CY2021	us-gaap	Payments For Software PaymentsForSoftware	9967000	USD
CY2020	us-gaap	Payments For Software PaymentsForSoftware	8678000	USD
CY2019	us-gaap	Payments For Software PaymentsForSoftware	9267000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37470000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18253000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24761000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43437000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	178004000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215356000	USD
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2020	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	USD
CY2019	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	315541000	USD
CY2021	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	43492000	USD
CY2021	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	26283000	USD
CY2021	real	Proceeds From Stock Options Exercised And Common Stock Warrants ProceedsFromStockOptionsExercisedAndCommonStockWarrants	6009000	USD
CY2020	real	Proceeds From Stock Options Exercised And Common Stock Warrants ProceedsFromStockOptionsExercisedAndCommonStockWarrants	8859000	USD
CY2019	real	Proceeds From Stock Options Exercised And Common Stock Warrants ProceedsFromStockOptionsExercisedAndCommonStockWarrants	2729000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2341000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	972000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	252913000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	real	Payments Related To Tax Withholding For Restricted Stock Vesting PaymentsRelatedToTaxWithholdingForRestrictedStockVesting	5000	USD
CY2020	real	Payments Related To Tax Withholding For Restricted Stock Vesting PaymentsRelatedToTaxWithholdingForRestrictedStockVesting	748000	USD
CY2019	real	Payments Related To Tax Withholding For Restricted Stock Vesting PaymentsRelatedToTaxWithholdingForRestrictedStockVesting	130000	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	9250000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	152815000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	378665000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	67325000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	196400000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	108819000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	350846000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	154446000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	45627000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	6584000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	11000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	553000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	94000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	90000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	418171000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	350846000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	154446000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	102000	USD
CY2021	real	Accretion Of Redeemable Convertible Preferred Stock To Redemption Value AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue	0	USD
CY2020	real	Accretion Of Redeemable Convertible Preferred Stock To Redemption Value AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue	0	USD
CY2019	real	Accretion Of Redeemable Convertible Preferred Stock To Redemption Value AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue	3355000	USD
CY2021	real	Purchase Of Property And Equipment Included In Accounts Payable And Other Accrued And Current Liabilities PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	1922000	USD
CY2020	real	Purchase Of Property And Equipment Included In Accounts Payable And Other Accrued And Current Liabilities PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	2638000	USD
CY2019	real	Purchase Of Property And Equipment Included In Accounts Payable And Other Accrued And Current Liabilities PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	4878000	USD
CY2021	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	1647000	USD
CY2020	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	338000	USD
CY2019	real	Purchases Of Capitalized Proprietary Software Development Costs Included In Accounts Payable And Other Accrued And Current Liabilities PurchasesOfCapitalizedProprietarySoftwareDevelopmentCostsIncludedInAccountsPayableAndOtherAccruedAndCurrentLiabilities	0	USD
CY2021	real	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	USD
CY2020	real	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	USD
CY2019	real	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	5333000	USD
CY2021	real	Conversion Of Convertible Preferred Stock Warrants In Connection With Initial Public Offering ConversionOfConvertiblePreferredStockWarrantsInConnectionWithInitialPublicOffering	0	USD
CY2020	real	Conversion Of Convertible Preferred Stock Warrants In Connection With Initial Public Offering ConversionOfConvertiblePreferredStockWarrantsInConnectionWithInitialPublicOffering	0	USD
CY2019	real	Conversion Of Convertible Preferred Stock Warrants In Connection With Initial Public Offering ConversionOfConvertiblePreferredStockWarrantsInConnectionWithInitialPublicOffering	2710000	USD
CY2021	real	Issuance Costs Associated With Issuance Of Convertible Senior Notes Included In Other Accrued And Current Liabilities IssuanceCostsAssociatedWithIssuanceOfConvertibleSeniorNotesIncludedInOtherAccruedAndCurrentLiabilities	0	USD
CY2020	real	Issuance Costs Associated With Issuance Of Convertible Senior Notes Included In Other Accrued And Current Liabilities IssuanceCostsAssociatedWithIssuanceOfConvertibleSeniorNotesIncludedInOtherAccruedAndCurrentLiabilities	469000	USD
CY2019	real	Issuance Costs Associated With Issuance Of Convertible Senior Notes Included In Other Accrued And Current Liabilities IssuanceCostsAssociatedWithIssuanceOfConvertibleSeniorNotesIncludedInOtherAccruedAndCurrentLiabilities	0	USD
CY2021	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1444000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2019	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0	USD
CY2021	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	3000	USD
CY2020	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	0	USD
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019	real	Tax Withholding Liability For Restricted Stock TaxWithholdingLiabilityForRestrictedStock	0	USD
CY2019Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	315500000	USD
CY2019Q3	real	Sale Of Stock Underwriting Discounts And Commissions SaleOfStockUnderwritingDiscountsAndCommissions	24100000	USD
CY2019Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5300000	USD
CY2019Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q3	real	Temporary Equity Conversion To Common Stock TemporaryEquityConversionToCommonStock	114960357	shares
CY2019Q3	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	58363606	shares
CY2019Q3	real	Common Stock Warrants Issued In Conversion CommonStockWarrantsIssuedInConversion	103563	shares
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of expenses during the reporting period. Significant items subject to such estimates and assumptions include those related to revenue recognition, including the returns reserve, valuation of inventory, software development costs, stock-based compensation, incremental borrowing rates related to lease liability, fair value of the liability component of convertible senior notes, valuation of deferred taxes, and other contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates.</span></div>
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021	us-gaap	Advertising Expense AdvertisingExpense	46200000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	45800000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	40500000	USD
CY2021Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	9100000	USD
CY2020Q4	real	Rights To Recover Products From Customers RightsToRecoverProductsFromCustomers	7400000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	5300000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18800000	USD
CY2019Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	300000	USD
CY2019Q4	real	Deferred Offering Cost Offset Against Proceeds From Initial Public Offering DeferredOfferingCostOffsetAgainstProceedsFromInitialPublicOffering	5300000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risks</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash and cash equivalents, restricted cash, accounts receivable, and investments. At times, such amount may exceed federally-insured limits. The Company reduces credit risk by placing its cash and cash equivalents, restricted cash, and investments with major financial institutions within the United States.</span></div>As of December 31, 2021 and December 31, 2020, there were no customers that represented 10% or more of the Company’s accounts receivable balance and there were no customers that individually exceeded 10% of the Company’s total revenue for each of the years ended December 31, 2021, 2020, and 2019.
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	418171000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	418171000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	350846000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	350846000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	4006000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	11000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	300000	USD
CY2020Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	4017000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	139634000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105401000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	50348000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	41947000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	89286000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	63454000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23500000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13400000	USD
CY2021Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	23577000	USD
CY2020Q4	real	Accrued Returns Reserve Current AccruedReturnsReserveCurrent	18327000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	14258000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13406000	USD
CY2021Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	14417000	USD
CY2020Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2537000	USD
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8935000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	6870000	USD
CY2021Q4	real	Site Credit Liability SiteCreditLiability	8738000	USD
CY2020Q4	real	Site Credit Liability SiteCreditLiability	5475000	USD
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	7897000	USD
CY2020Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8253000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1166000	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	216000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3387000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1617000	USD
CY2021Q4	real	Accrued Inventory AccruedInventory	3513000	USD
CY2020Q4	real	Accrued Inventory AccruedInventory	470000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	8300000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4691000	USD
CY2021Q4	real	Other Accrued And Current Liabilities OtherAccruedAndCurrentLiabilities	94188000	USD
CY2020Q4	real	Other Accrued And Current Liabilities OtherAccruedAndCurrentLiabilities	61862000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	0	USD
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	287500000	USD
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	22234811	shares
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	20534859	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019Q4	real	Weighted Average Grant Date Fair Value Of Options Granted WeightedAverageGrantDateFairValueOfOptionsGranted	8.60
CY2021Q4	real	Aggregate Intrinsic Value Of Options Exercised AggregateIntrinsicValueOfOptionsExercised	20500000	USD
CY2020Q4	real	Aggregate Intrinsic Value Of Options Exercised AggregateIntrinsicValueOfOptionsExercised	32200000	USD
CY2019Q4	real	Aggregate Intrinsic Value Of Options Exercised AggregateIntrinsicValueOfOptionsExercised	16200000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.442
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.478
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.019
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.026
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	3600000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2021	real	Share Based Compensation Expense Excludes Share Based Compensation Related To Stock Sales By Current And Former Employees ShareBasedCompensationExpenseExcludesShareBasedCompensationRelatedToStockSalesByCurrentAndFormerEmployees	48802000	USD
CY2020	real	Share Based Compensation Expense Excludes Share Based Compensation Related To Stock Sales By Current And Former Employees ShareBasedCompensationExpenseExcludesShareBasedCompensationRelatedToStockSalesByCurrentAndFormerEmployees	24322000	USD
CY2019	real	Share Based Compensation Expense Excludes Share Based Compensation Related To Stock Sales By Current And Former Employees ShareBasedCompensationExpenseExcludesShareBasedCompensationRelatedToStockSalesByCurrentAndFormerEmployees	7711000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	29700000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	24700000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	3900000	USD
CY2019	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18100000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	27436000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28268000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	27998000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	28648000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	28201000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	58806000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	199357000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	37946000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	161411000	USD
CY2021	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	25386000	USD
CY2020	real	Cash Paid For Amounts Included In Measurement Of Lease Liabilities CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities	21381000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	46614000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	23853000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y1M6D
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y3M18D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066
CY2021Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	7431000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	4423000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	1139000	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	0	USD
CY2021Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	0	USD
CY2021Q4	us-gaap	Purchase Obligation PurchaseObligation	12993000	USD
CY2021Q4	real	Grant Liability GrantLiability	0	USD
CY2021	real	Payment Of Grant Liability PaymentOfGrantLiability	500000	USD
CY2020Q4	real	Grant Liability GrantLiability	500000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	56000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	101000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	199000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	56000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	101000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	199000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	199000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-49480000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-36559000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-20272000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-13704000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-10315000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-5170000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2698000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-6261000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	750000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3661000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	402000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	679000	USD
CY2021	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	16782000	USD
CY2020	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	0	USD
CY2019	real	Effective Income Tax Rate Reconciliation Convertible Notes Amount EffectiveIncomeTaxRateReconciliationConvertibleNotesAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	42327000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	52834000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	24212000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	3168000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	56000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	101000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	199000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	178558000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	129333000	USD
CY2021Q4	real	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	2915000	USD
CY2020Q4	real	Deferred Tax Assets Fixed Assets And Intangible Assets DeferredTaxAssetsFixedAssetsAndIntangibleAssets	3794000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8202000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	6008000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5007000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3147000	USD
CY2021Q4	real	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	43345000	USD
CY2020Q4	real	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	35267000	USD
CY2021Q4	real	Deferred Tax Assets Capped Calls DeferredTaxAssetsCappedCalls	15095000	USD
CY2020Q4	real	Deferred Tax Assets Capped Calls DeferredTaxAssetsCappedCalls	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	253122000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	177549000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	185541000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	143214000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	67581000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	34335000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	39021000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	32028000	USD
CY2021Q4	real	Deferred Tax Liabilities Convertible Debt DeferredTaxLiabilitiesConvertibleDebt	26477000	USD
CY2020Q4	real	Deferred Tax Liabilities Convertible Debt DeferredTaxLiabilitiesConvertibleDebt	0	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2083000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	2307000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	67581000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	34335000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	42300000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	54800000	USD
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.14
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-175832000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-101784000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	91409624	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-236107000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	91409624	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	87587409	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	87587409	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47478544	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47478544	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.58
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.58
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.01
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.01
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.14
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31213281	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20728286	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9961573	shares
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.25
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1100000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	800000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	500000	USD

Files In Submission

Name	View Source	Status
0001573221-22-000041-index-headers.html	Edgar Link	pending
0001573221-22-000041-index.html	Edgar Link	pending
0001573221-22-000041.txt	Edgar Link	pending
0001573221-22-000041-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
real-20201231xex312.htm	Edgar Link	pending
real-20201231xex321.htm	Edgar Link	pending
real-20211231.htm	Edgar Link	pending
real-20211231.xsd	Edgar Link	pending
real-20211231xex1034.htm	Edgar Link	pending
real-20211231xex231.htm	Edgar Link	pending
real-20211231xex311.htm	Edgar Link	pending
real-20211231xex322.htm	Edgar Link	pending
real-20211231_cal.xml	Edgar Link	unprocessable
real-20211231_def.xml	Edgar Link	unprocessable
real-20211231_g1.jpg	Edgar Link	pending
real-20211231_g2.jpg	Edgar Link	pending
real-20211231_g3.jpg	Edgar Link	pending
real-20211231_g4.jpg	Edgar Link	pending
real-20211231_g5.jpg	Edgar Link	pending
real-20211231_g6.jpg	Edgar Link	pending
real-20211231_htm.xml	Edgar Link	completed
real-20211231_lab.xml	Edgar Link	unprocessable
real-20211231_pre.xml	Edgar Link	unprocessable
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$REAL
TheRealReal, Inc. Stock $real

2021 Q4 Form 10-K Financial Statement

#000157322122000041 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL TheRealReal, Inc. Stock $real

2021 Q4 Form 10-K Financial Statement

#000157322122000041 Filed on February 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$REAL
TheRealReal, Inc. Stock $real